Market Tracker

08/31 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

6.84
Delayed Data
As of Aug 31
 -0.12 / -1.72%
Today’s Change
4.08
Today|||52-Week Range
11.70
-18.47%
Year-to-Date

Today’s Trading

Previous close6.96
Today’s open7.00
Day’s range6.78 - 7.02
Volume3,367,940
Average volume (3 months)5,040,454
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-78.49%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book6.42

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.53-3.01%
ARIAARIAD Pharmaceutical...-0.09-0.86%
EXASExact Sciences Corp-0.46-2.43%
ONCESpark Therapeutics I...+0.26+0.46%
Data as of 4:00pm ET, 08/31/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts